The FDA has approved the Lantidra allogeneic pancreatic islet cellular therapy developed by CellTrans to treat diabetes. This is the first approval of a donor
Beta Bionics has raised private funding of $100m to support commercialization and further development of iLet Bionic Pancreas, its recently-authorized automated insulin dosing (AID) system, which
Abbott and Bigfoot Biomedical have announced a definitive agreement for Abbott to acquire Bigfoot, a leader in developing smart insulin management systems for people with diabetes.
New data suggests that significant reductions in HbA1c have occurred over time among adults with Type 1 diabetes as their use of diabetes technology has
Bigfoot’s diabetes management system is designed to address problems such as missed doses, inadequate insulin intensification and dosing errors that affect people with diabetes who
Sernova has entered into a preclinical research collaboration on drug delivery with AstraZeneca, with the aim of evaluating the use of Sernova’s Cell Pouch System
Hundreds of British children with Type 2 diabetes who currently manage their condition with ‘burdensome’ finger prick blood testing several times a day could be
Diabetes UK (DUK) has marked Diabetes Week by launching a campaign to call for fair and equal access to diabetes tech. A recent DUK press
Ypsomed is to expand its offering of digital health solutions in partnership with S3 Connected Health. Headquartered in Dublin, S3 Connected Health is a specialist
Roche has announced that real world data shows a significant improvement in glycaemic management when using a blood glucose monitor connected to the mySugr mobile
